ChemT Biotechnology
Summary active Updated Jun 29, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
ChemT Biotechnology is a Singapore-based AI-driven biotech company building CelMo, a virtual-cell platform that simulates how cells respond to manufacturing conditions and genetic changes in order to optimize biomanufacturing production processes 12. ChemT was founded in 2024 by Jie Sun (Co-Founder & CEO) and Dr. Ling Wu, and says it has built commercial partnerships with more than 40 pharmaceutical, biotech, and CDMO companies globally within roughly 18 months of launch 12. The June 2026 seed brings total funding to roughly $5 million, including $1 million in prior angel investment 12.
Disclaimer: This is a lean profile built from initial round coverage and may be expanded as more information becomes available.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-06-23 | Seed | $4M | Wavemaker Ventures | SEEDS (SG Growth Capital), Wavemaker 360 Health, Draper University Ventures, Temasek Life Sciences Accelerator 12 |
What Investors Say
“ChemT’s precision small molecules give manufacturers a new lever for faster, cheaper, and higher-yield production.” — Paul Santos, Co-Founder, Wavemaker Partners 1
What Founders Say
“Within roughly a year and a half of launch, ChemT has built commercial partnerships with more than 40 pharmaceutical, biotech, and CDMO companies globally.” — Jie Sun, Co-Founder & CEO, ChemT 1
Sources
-
TNGlobal, “Singapore’s ChemT Biotechnology raises $4M seed round to build AI intelligence layer for biomanufacturing,” June 23, 2026. Accessed June 2026. https://technode.global/2026/06/23/singapores-chemt-biotechnology-raises-4m-seed-round-to-build-ai-intelligence-layer-for-biomanufacturing/↩↩↩↩↩↩
-
FinSMEs, “ChemT Biotechnology Raises $4M in Seed Funding,” June 2026. Accessed June 2026. https://www.finsmes.com/2026/06/chemt-biotechnology-raises-4m-in-seed-funding.html↩↩↩↩